[Therapeutic possibilities in spasticity. Review].
D001583:Benzoxazoles / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000150:complications / Q000188:drug therapy; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003286:Contracture / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D008615:Mephenesin / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D008721:Methocarbamol / Q000627:therapeutic use; D009069:Movement Disorders / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000628:therapy*; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D009493:Neurosurgery; D009966:Orphenadrine / Q000627:therapeutic use; D010300:Parkinson Disease / Q000628:therapy; D010640:Phenothiazines / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D010880:Piperidines / Q000627:therapeutic use; D011343:Procaine / Q000008:administration & dosage; D014149:Tranquilizing Agents / Q000627:therapeutic use; D015049:Zoxazolamine / Q000627:therapeutic use
D001583:Benzoxazoles; D009125:Muscle Relaxants, Central; D003473:Neuromuscular Nondepolarizing Agents; D010640:Phenothiazines; D010880:Piperidines; D014149:Tranquilizing Agents; D008721:Methocarbamol; D011343:Procaine; D002707:Chlordiazepoxide; D008615:Mephenesin; D015049:Zoxazolamine; D008620:Meprobamate; D009966:Orphenadrine; D003975:Diazepam; D002746:Chlorpromazine
Posibilitaţi terapeutice în spasticitate. Referat general.